Type A and B Monoamine Oxidase in Age-Related Neurodegenerative Disorders: Their Distinct Roles in Neuronal Death and Survival

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|12|20|2177-2188

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.12, Iss.20, 2012-10, pp. : 2177-2188

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoamine Oxidase Inhibitors as Neuroprotective Agents in Age-Dependent Neurodegenerative Disorders

By  

Current Pharmaceutical Design, Vol. 16, Iss. 25, 2010-08 ,pp. : 2799-2817

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Application of Intrabodies Against Age-Related Neurodegenerative Disorders

By  

Current Pharmaceutical Design, Vol. 20, Iss. 38, 2014-11 ,pp. : 6028-6036

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Uric Acid and Methyl Derivatives in the Prevention of Age-Related Neurodegenerative Disorders

By  

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 21, 2015-01 ,pp. : 2233-2238

Bentham Science Publishers

Access to resources Recommend Favorite

Monoamine oxidase A and B inhibitors

By Jegham S.   George P.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 9, 1998-09 ,pp. : 1143-1150

Informa Healthcare

Access to resources Recommend Favorite

The increasing role of monoamine oxidase type B inhibitors in Parkinson's disease therapy

By Elmer Lawrence W   Bertoni John M  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 16, 2008-11 ,pp. : 2759-2772

Informa Healthcare

Access to resources Recommend Favorite